• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [17762 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2020     Andalusian Health Technology Assessment Area (AETSA) Genetic risk prediction test for cardiovascular disease
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical Efectiveness of Newborn Screening for Inborn Errors of Metabolism by MS/ MS. Update and pilot study assessment: Maple Syrup Urine Disease; Isovaleric Acidaemia; Homocystinuria]
2020     Andalusian Health Technology Assessment Area (AETSA) Efficacy, effectivity and safety of physical therapies for neuromuscular diseases: systematic review
2020     European Network for Health Technology Assessment (EUnetHTA) Hypoglossal nerve stimulation systems for treatment of obstructive sleep apnea
2020     Andalusian Health Technology Assessment Area (AETSA) Effectiveness and safety of MAGnetic Expansion Control (MAGEC) growing rods. Evidence Update.
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Treatment of benign thyroid by thermal laser or radiofrequency ablation]
2020     NIHR Health Technology Assessment programme Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review
2020     European Network for Health Technology Assessment (EUnetHTA) Biodegradable rectum spacers to reduce toxicity for prostate cancer
2020     European Network for Health Technology Assessment (EUnetHTA) The 24-hour blood pressure measurement device Mobil-O-Graph® with the built-in algorithm ARCSolver® to measure arterial stiffness for the optimization of hypertension treatment and assessment of cardiovascular disease risk
2020     NIHR Health Technology Assessment programme Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review
2020     NIHR Health Technology Assessment programme Occupational advice to help people return to work following lower limb arthroplasty: the OPAL intervention mapping study
2020     NIHR Health Services and Delivery Research programme Medication management in older people: the MEMORABLE realist synthesis
2020     European Network for Health Technology Assessment (EUnetHTA) Lung cancer screening in risk groups
2020     NIHR Health Technology Assessment programme Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
2020     European Network for Health Technology Assessment (EUnetHTA) Rapid collaborative review on the current role of antibody tests for novel coronavirus SARS-COV-2 in the management of the pandemic
2020     European Network for Health Technology Assessment (EUnetHTA) Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of SARS-COV-2 virus in people with suspected COVID-19
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home-based oral nutritional supplements in cancer patients who require modification of the usual ordinary diet due to mucositis]
2020     European Network for Health Technology Assessment (EUnetHTA) Lopinavir and ritonavir for the treatment of COVID-19
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home-based oral nutritional supplements in cancer patients with moderate-severe malnutrition undergoing active treatment]
2020     Norwegian Institute of Public Health (NIPH) Abdominal aorta aneurysm (AAA) screening of men aged 65
2020     NIHR Health Services and Delivery Research programme Enhancing the credibility, usefulness and relevance of patient experience data in services for people with long-term physical and mental health conditions using digital data capture and improved analysis of narrative data (DEPEND)
2020     NIHR Health Services and Delivery Research programme The role of hospital organisation, surgical factors, and the enhanced recovery pathway, on patient outcomes and NHS costs following primary hip and knee replacement surgery: spatial and longitudinal analysis of routine data
2020     NIHR Health Services and Delivery Research programme Implementation of an evidence based pelvic floor muscle training intervention for women with pelvic organ prolapse (PROlapse and PFMT: implementing Evidence Locally - PROPEL)
2020     Health Technology Wales (HTW) Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of the SARS-COV-2 virus in people with suspected COVID-19
2020     NIHR Health Services and Delivery Research programme ERA Electronic Records in Ambulances to support the shift to out of hospital care: challenges, opportunities and workforce implications
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: continuous glucose monitoring system (Dexcom G6, Dexcom)]
2020     NIHR Health Services and Delivery Research programme Dementia undetected or undiagnosed in primary care: the prevalence, causes and consequences
2020     NIHR Health Technology Assessment programme Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Takhzyro (lanadelumab), notice of inclusion on the Liste des produits du système du sang du Québec]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020     NIHR Health Technology Assessment programme An online randomised controlled trial to evaluate the clinical and cost effectiveness of a peer supported self-management intervention for relatives of people with psychosis or bipolar disorder: Relatives Education And Coping Toolkit (REACT)
2020     Swiss Federal Office of Public Health (FOPH) Dual antiplatelet therapy following percutaneous coronary intervention
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use of immunoglobulins in hematology]
2020     Swiss Federal Office of Public Health (FOPH) Vitamin D testing
2020     NIHR Health Technology Assessment programme Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use of immunoglobulins in clinical immunology]
2020     NIHR Health Services and Delivery Research programme Optimising acute care for people with dementia: a mixed-methods study
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: use of sedation and general anesthesia in pediatric dental care]
2020     NIHR Health Services and Delivery Research programme Dementia and cognitive impairment in the older prison population of England and Wales: identifying individual need and developing a skilled, multi-agency workforce to deliver targeted and responsive services
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the therapeutic value of hyperbaric oxygen (HBO) on children with cerebral palsy]
2020     Austrian Institute for Health Technology Assessment (AIHTA) Genetic testing in the context of familial hypercholesterolaemia management. Organisational and ethical implications (part 1), and economic aspects (part 2)
2020     Austrian Institute for Health Technology Assessment (AIHTA) [Lung cancer screening in risk groups]
2020     NIHR Health Services and Delivery Research programme Access to primary and community health-care services for people 16 years and over with intellectual disabilities: a mapping and targeted systematic review
2020     Basque Office for Health Technology Assessment (OSTEBA) [Efficacy and safety of mechanical thrombectomy in the treatment of patients with ischaemic stroke beyond 6 hours after onset or with an unknown time of onset]
2020     Austrian Institute for Health Technology Assessment (AIHTA) Lung cancer screening in risk groups: a review-update of the economic evidence (Part II)
2020     Basque Office for Health Technology Assessment (OSTEBA) [Neonatal hearing screening programmes: A systematic review of economic evaluation studies and descriptive analysis of Spanish regional programmes]
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020     Center for Evidence-based Practice (CEP) COVID-19: protecting health care workers' (HCW) families at home
2020     Ontario Health Automated CT perfusion imaging to aid in the selection of patients with acute ischemic stroke for mechanical thrombectomy
2020     Ontario Health Home narrowband ultraviolet B phototherapy for photoresponsive skin conditions
2020     Ontario Health Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment
2020     Center for Evidence-based Practice (CEP) COVID-19: corticosteroids for hospitalized patients
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: acute exacerbation of chronic obstructive pulmonary disease]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: The Argus II retinal implant]
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: approach to managing access to cancer care: a review of the literature and practices]
2019     NIHR Health Technology Assessment programme Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019     NIHR Health Technology Assessment programme Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma]leukemia]
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia]
2019     NIHR Horizon Scanning Centre (NIHR HSC) An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study
2019     Norwegian Institute of Public Health (NIPH) Organ donation with the use of normothermic regional perfusion in patients who die after cardiac and respiratory arrest after withdrawal of life-sustaining treatment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: breast tomosynthesis and breast cancer screening]
2019     NIHR Health Technology Assessment programme Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: treatment of mitral regurgitation by a percutaneous device with clip (TMVRc)]
2019     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Stereotactic neurosurgery frameless. The iSYS1® Robotic device]
2019     Norwegian Institute of Public Health (NIPH) Disease modifying treatments for relapsing remitting multiple sclerosis. A health economic evaluation
2019     Norwegian Institute of Public Health (NIPH) Disease-modifying treatments for relapsing remitting multiple sclerosis, including rituximab. A health technology assessment
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ external condylomas (anogenital warts)]
2019     Andalusian Health Technology Assessment Area (AETSA) PET usefulness in non-oncological indications
2019     Norwegian Institute of Public Health (NIPH) Prehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: best strategies for reducing the risk of severe toxicities caused by dihydropyrimidine dehydrogenase deficiency]
2019     Andalusian Health Technology Assessment Area (AETSA) Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
2019     Norwegian Institute of Public Health (NIPH) Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
2019     Norwegian Institute of Public Health (NIPH) Health technology assessment of Transcatether aortic valve implantation (TAVI) as treatment of patients with severe aortic stenosis and intermediate surgical risk – Part 2. Health economic evaluation
2019     Norwegian Institute of Public Health (NIPH) Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke
2019     Norwegian Institute of Public Health (NIPH) Hyperbaric oxygen therapy for osteonecrosis
2019     NIHR Public Health Research (PHR) programme Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence
2019     NIHR Health Technology Assessment programme Trial of Acute Femoral Fracture Fixation (TrAFFix). A feasibility study
2019     Adelaide Health Technology Assessment (AHTA) Alpha Thalassaemia genetic testing
2019     Swiss Federal Office of Public Health (FOPH) Scoping report for the evaluation of the removal of osteosynthesis materials in Switzerland
2019     Swiss Federal Office of Public Health (FOPH) Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2019     Swiss Federal Office of Public Health (FOPH) Assessment of knee arthroscopy for the treatment of degenerative changes
2019     NIHR Health Services and Delivery Research programme Innovation to enhance health in care homes: rapid evidence synthesis
2019     NIHR Health Services and Delivery Research programme Improving NHS quality using internet ratings and experiences (INQUIRE)
2019     NIHR Health Services and Delivery Research programme Evaluation of specialist nursing support for carers of people with dementia
2019     NIHR Health Services and Delivery Research programme Understanding and enhancing how hospital staff learn from and act on patient experience data
2019     NIHR Health Services and Delivery Research programme A study of sense-making strategies and help-seeking behaviours associated with the use and provision of urgent care services
2019     Center for Evidence-based Practice (CEP) The Effect of Patient Communication About Medical Errors on Malpractice Lawsuits
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2019     Center for Evidence-based Practice (CEP) Interventions to Reduce the Use of the High Risk Medications in Elderly Patients
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Natalizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019     Center for Evidence-based Practice (CEP) Guidelines for Supplementary Feedings of Newborn Infants
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report